锦华新材IPO闪电注册:曾将四成资金放在母公司巨化集团,浙商证券保荐

Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. has successfully registered for an IPO on the Beijing Stock Exchange, with the underwriting by Zheshang Securities and auditing by Tianjian Accounting Firm [1][3] Company Overview - Jinhua New Materials was established in December 2007 and specializes in the research, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [3] - The company is a leading player in the domestic market for silane crosslinking agents and hydroxylamine salts [3] Financial Performance - The company's revenue for 2022, 2023, and 2024 was reported as 994 million, 1.115 billion, and 1.239 billion respectively, with net profits (after deducting non-recurring gains and losses) of 78.42 million, 173 million, and 206 million [4] - For Q1 2025, the revenue was 282 million, a decrease of 9.98% year-on-year, with net profit down 16.89% to 50.51 million [4] - Management forecasts for H1 2025 indicate expected revenue between 560 million to 600 million, a decline of 7.14% to 13.33% compared to the previous year, and net profit between 109 million to 117 million, down 8.79% to 15.02% [5] Shareholding Structure - The controlling shareholder of Jinhua New Materials is Juhua Group Co., Ltd., which holds 82.49% of the shares, while the actual controller is the Zhejiang Provincial State-owned Assets Supervision and Administration Commission [6] Financial Management - The company has maintained deposits with Juhua Group's financial company, with balances of 161 million, 165 million, and 0 in the respective years, indicating a decreasing trend in the proportion of total monetary funds [7] - In 2022, the company decided to terminate the automatic transfer of funds to Juhua Group's financial company to enhance its financial independence [8]